June 8, 2024

Digital Mammography Market Size To Rake USD 6.04 Bn By 2032

The global digital mammography market size was valued at USD 2.21 billion in 2022 and is projected to reach USD 6.04 billion by 2032, growing at a CAGR of 10.57% from 2023 to 2032, According to Precedence Research.

Digital Mammography Market Size 2023 To 2032

The global digital mammography market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.

Download The Sample Copy For Better Understanding@ https://www.precedenceresearch.com/sample/3053

Digital Mammography Market Report Scope

Report Coverage Details
Market Size in 2023 USD 2.45 Billion
Market Size by 2032 USD 6.04 Billion
Growth Rate from 2023 to 2032 CAGR of 10.57%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By product and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Also read: Small Cell Lung Cancer Therapeutics Market Size To Rake USD 16.33 Bn By 2032

Benefits of this market

  • This study analyses the market size and share for digital mammography along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
  • In order to compare the financial capabilities of the digital mammography market in the present, a quantitative analysis is done of the market from 2023 to 2032.
  • It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
  • It is important to understand the most profitable trends in the digital mammography market in order to gain an advantage in the market.
  • A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
  • The report also includes the market share for digital mammography for several significant vendors as well as the latest developments in the market.

Leading players of the global digital mammography market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global digital mammography market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global digital mammography market. It also provides useful recommendations for new as well as established players of the global digital mammography market.

The major players in the market

  • Hologic Inc.
  • Koninklijke Philips NV
  • GE Healthcare
  • Siemens Healthcare GmBH
  • PLANMED OY
  • Fujifilm Corporation
  • Toshiba Medical Systems
  • Metaltronica S.p.A

Digital Mammography Market Segmentations:

By product

  • 3D Full Field Digital Mammography Tomosynthesis
  • 2D Full Field Digital Mammography Tomosynthesis

By End-use

  • Diagnostic Centers
  • Hospitals
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Digital Mammography Market 

5.1. COVID-19 Landscape: Digital Mammography Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Digital Mammography Market, By Product

8.1. Digital Mammography Market Revenue and Volume, by Product, 2023-2032

8.1.1. 3D Full Field Digital Mammography Tomosynthesis

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. 2D Full Field Digital Mammography Tomosynthesis

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Digital Mammography Market, By End-use

9.1. Digital Mammography Market Revenue and Volume, by End-use, 2023-2032

9.1.1. Diagnostic Centers

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Digital Mammography Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.1.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.1.3.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.1.4.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.2.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.2.3.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.2.4.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.2.5.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.2.6.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.3.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.3.3.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.3.4.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.3.5.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.3.6.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.4.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.4.3.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.4.4.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.4.5.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.4.6.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.5.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.5.3.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

10.5.4.2. Market Revenue and Volume Forecast, by End-use (2020-2032)

Chapter 11. Company Profiles

11.1. Hologic Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Koninklijke Philips NV

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. GE Healthcare

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Siemens Healthcare GmBH

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. PLANMED OY

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Fujifilm Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Toshiba Medical Systems

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Metaltronica S.p.A

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Key inquiries addressed in the report:

  • Investigate the COVID 19 outbreak’s effects.
  • Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Leave a Reply

Your email address will not be published. Required fields are marked *